HomeIndustriesTechnologyOverlooked Stock: QNTM

Overlooked Stock: QNTM

Quantum's in the name but has no part of the business. Quantum BioPharma (QNTM) is up over 130% year to date but has fallen more than 50% off its all-time high. George Tsilis notes the interesting drugs it's developing can reach corners of the market sometimes ignored. The issue? Quantum's lack of revenue, which George says needs to reverse for these products to get on shelves.

Market On Close

28 Mar 2025

SHARE

ON AIR
8:30 am
Market Overtime
replay
12:00 am
Trading 360
REPLAY
1:00 am
Fast Market
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
education
3:30 am
Inside the Mind of a Trader
REPLAY
education
4:00 am
Inside the Mind of a Trader
REPLAY
education
4:30 am
Inside the Mind of a Trader
REPLAY
education
5:00 am
Your First Trade
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Market Overtime
REPLAY
education
7:00 am
Inside the Mind of a Trader
REPLAY
education
7:30 am
Inside the Mind of a Trader
REPLAY
education
8:00 am
Inside the Mind of a Trader
REPLAY
ON AIR
8:30 am
Market Overtime
REPLAY
education
9:00 am
Your First Trade
REPLAY
education
9:30 am
Your First Trade
REPLAY
education
10:00 am
Your First Trade
REPLAY
education
10:30 am
Your First Trade
REPLAY
education
11:00 am
Your First Trade
REPLAY
education
11:30 am
Your First Trade
REPLAY
education
12:00 pm
Your First Trade
REPLAY
education
12:30 pm
Your First Trade
REPLAY
education
1:00 pm
Your First Trade
REPLAY
education
1:30 pm
Your First Trade
REPLAY
2:00 pm
Trading 360
REPLAY
3:00 pm
Fast Market
REPLAY
4:00 pm
Next Gen Investing
REPLAY
5:00 pm
Market Overtime
REPLAY
education
5:30 pm
Inside the Mind of a Trader
REPLAY
education
6:00 pm
Inside the Mind of a Trader
REPLAY
education
6:30 pm
Inside the Mind of a Trader
REPLAY
7:00 pm
Market Overtime
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market Overtime
REPLAY
9:00 pm
Trading 360
REPLAY
10:00 pm
Fast Market
REPLAY
11:00 pm
Next Gen Investing
REPLAY

Schwab Network's Newsletters

Daily insights for every investor